{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:56:43Z","timestamp":1787770603714,"version":"build-2784847793"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1178119"],"award-info":[{"award-number":["OPP1178119"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P51OD011092"],"award-info":[{"award-number":["P51OD011092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U54HD055744"],"award-info":[{"award-number":["U54HD055744"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["U01HD076542"],"award-info":[{"award-number":["U01HD076542"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>WEE2 oocyte meiosis inhibiting kinase is a well-conserved oocyte specific kinase with a dual regulatory role during meiosis. Active WEE2 maintains immature, germinal vesicle stage oocytes in prophase I arrest prior to the luteinizing hormone surge and facilitates exit from metaphase II arrest at fertilization. Spontaneous mutations at the WEE2 gene locus in women have been linked to total fertilization failure indicating that selective inhibitors to this kinase could function as non-hormonal contraceptives. Employing co-crystallization with WEE1 G2 checkpoint kinase inhibitors, we revealed the structural basis of action across WEE kinases and determined type I inhibitors were not selective to WEE2 over WEE1. In response, we performed in silico screening by FTMap\/FTSite and Schrodinger SiteMap analysis to identify potential allosteric sites, then used an allosterically biased activity assay to conduct high-throughput screening of a 26 000 compound library containing scaffolds of known allosteric inhibitors. Resulting hits were validated and a selective inhibitor that binds full-length WEE2 was identified, designated GPHR-00336382, along with a fragment-like inhibitor that binds the kinase domain, GPHR-00355672. Additionally, we present an in vitro testing workflow to evaluate biological activity of candidate WEE2 inhibitors including; (1) enzyme-linked immunosorbent assays measuring WEE2 phosphorylation activity of cyclin dependent kinase 1 (CDK1; also known as cell division cycle 2 kinase, CDC2), (2) in vitro fertilization of bovine ova to determine inhibition of metaphase II exit, and (3) cell-proliferation assays to look for off-target effects against WEE1 in somatic (mitotic) cells.<\/jats:p>","DOI":"10.1093\/biolre\/ioaa097","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T14:59:06Z","timestamp":1591973946000},"page":"368-377","source":"Crossref","is-referenced-by-count":16,"title":["Development of WEE2 kinase inhibitors as novel non-hormonal female contraceptives that target meiosis\u2020"],"prefix":"10.1093","volume":"103","author":[{"given":"Carol B","family":"Hanna","sequence":"first","affiliation":[{"name":"Oregon National Primate Research Center, Beaverton, Division of Reproductive & Developmental Sciences OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepti","family":"Mudaliar","sequence":"additional","affiliation":[{"name":"University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"John","sequence":"additional","affiliation":[{"name":"University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Leigh","family":"Allen","sequence":"additional","affiliation":[{"name":"University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxin","family":"Sun","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Drug Discovery Department, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon E","family":"Hawkinson","sequence":"additional","affiliation":[{"name":"University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Sch\u00f6nbrunn","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Drug Discovery Department, Tampa, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunda I","family":"Georg","sequence":"additional","affiliation":[{"name":"University of Minnesota, Department of Obstetrics & Gynecology, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T","family":"Jensen","sequence":"additional","affiliation":[{"name":"Oregon National Primate Research Center, Beaverton, Division of Reproductive & Developmental Sciences OR, USA"},{"name":"Oregon Health & Science University, Portland, OR, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"2020080407010988900_ref1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3109\/09513590.2014.950648","article-title":"Mechanisms of action of oral emergency contraception","volume":"30","author":"Gemzell-Danielsson","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"2020080407010988900_ref2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.ph.50.030188.002301","article-title":"Molecular aspects of hormone action in ovarian follicular development, ovulation, and luteinization","volume":"50","author":"Richards","year":"1988","journal-title":"Annu Rev Physiol"},{"key":"2020080407010988900_ref3","doi-asserted-by":"crossref","DOI":"10.1530\/rep.1.00793","article-title":"Stops and starts in mammalian oocytes: recent advances in understanding the regulation of meiotic arrest and oocyte maturation","volume":"130","author":"Mehlmann","year":"2005","journal-title":"Reproduction"},{"key":"2020080407010988900_ref4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1530\/rep.1.00824","article-title":"An active protein kinase A (PKA) is involved in meiotic arrest of rat growing oocytes","volume":"132","author":"Kovo","year":"2006","journal-title":"Reproduction"},{"key":"2020080407010988900_ref5","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.200907161","article-title":"Wee1B, Myt1, and Cdc25 function in distinct compartments of the mouse oocyte to control meiotic resumption","volume":"188","author":"Oh","year":"2010","journal-title":"J Cell Biol"},{"key":"2020080407010988900_ref6","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/molehr\/gaq034","article-title":"Prophase I arrest and progression to metaphase I in mouse oocytes: Comparison of resumption of meiosis and recovery from G2-arrest in somatic cells","volume":"16","author":"Solc","year":"2010","journal-title":"Mol Hum Reprod"},{"key":"2020080407010988900_ref7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1172\/JCI2566","article-title":"Phosphodiesterase 3 inhibitors suppress oocyte maturation and consequent pregnancy without affecting ovulation and cyclicity in rodents","volume":"102","author":"Wiersma","year":"1998","journal-title":"J Clin Investig"},{"key":"2020080407010988900_ref8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.contraception.2004.07.007","article-title":"The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation during gonadotropin-stimulated ovarian cycles in rhesus macaques","volume":"71","author":"Jensen","year":"2005","journal-title":"Contraception"},{"key":"2020080407010988900_ref9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.contraception.2009.09.015","article-title":"Evaluation of the phosphodiesterase 3 inhibitor ORG 9935 as a contraceptive in female macaques: initial trials","volume":"81","author":"Jensen","year":"2010","journal-title":"Contraception"},{"key":"2020080407010988900_ref10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1242\/dev.00340","article-title":"Ca2+ oscillations at fertilization in mammals are regulated by the formation of pronuclei","volume":"130","author":"Marangos","year":"2003","journal-title":"Development"},{"key":"2020080407010988900_ref11","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.1384126","article-title":"Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase","volume":"257","author":"Parker","year":"1992","journal-title":"Science (New York, NY)"},{"key":"2020080407010988900_ref12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1046\/j.1365-2443.2000.00367.x","article-title":"Identification and characterization of human Wee1B, a new member of the Wee1 family of Cdk-inhibitory kinases","volume":"5","author":"Nakanishi","year":"2000","journal-title":"Genes Cells"},{"key":"2020080407010988900_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbaexp.2005.02.006","article-title":"Identification of a novel Wee1 isoform","volume":"1729","author":"Yu","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"2020080407010988900_ref14","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1095\/biolreprod.109.081984","article-title":"WEE2 is an oocyte-specific meiosis inhibitor in rhesus macaque monkeys","volume":"82","author":"Hanna","year":"2010","journal-title":"Biol Reprod"},{"key":"2020080407010988900_ref15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ajhg.2018.02.015","article-title":"Homozygous mutations in WEE2 cause fertilization failure and female infertility","volume":"102","author":"Sang","year":"2018","journal-title":"Am J Hum Genet"},{"key":"2020080407010988900_ref16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tcb.2016.09.002","article-title":"Mechanisms of aneuploidy in human eggs","volume":"27","author":"Webster","year":"2017","journal-title":"Trends Cell Biol"},{"key":"2020080407010988900_ref17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.fertnstert.2018.11.013","article-title":"New biallelic mutations in WEE2: expanding the spectrum of mutations that cause fertilization failure or poor fertilization","volume":"111","author":"Dai","year":"2019","journal-title":"Fertil Steril"},{"key":"2020080407010988900_ref18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.fertnstert.2018.11.018","article-title":"Novel WEE2 gene variants identified in patients with fertilization failure and female infertility","volume":"111","author":"Zhao","year":"2019","journal-title":"Fertil Steril"},{"key":"2020080407010988900_ref19","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s10815-019-01553-3","article-title":"Novel compound heterozygous mutations in WEE2 causes female infertility and fertilization failure","volume":"36","author":"Zhou","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2020080407010988900_ref20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10815-019-01418-9","article-title":"Homozygous missense mutation Arg207Cys in the WEE2 gene causes female infertility and fertilization failure","volume":"36","author":"Yang","year":"2019","journal-title":"J Assist Reprod Genet"},{"key":"2020080407010988900_ref21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cge.13505","article-title":"Novel mutations in WEE2: expanding the spectrum of mutations responsible for human fertilization failure","volume":"95","author":"Zhang","year":"2019","journal-title":"Clin Genet"},{"key":"2020080407010988900_ref22","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1002\/slct.201903696","article-title":"Identification and screening of selective WEE2 inhibitors to develop non-hormonal contraceptives that specifically target meiosis","volume":"4","author":"Hanna","year":"2019","journal-title":"ChemistrySelect"},{"key":"2020080407010988900_ref23","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1021\/acs.jmedchem.7b00996","article-title":"Structural basis of wee kinases functionality and inactivation by diverse small molecule inhibitors","volume":"60","author":"Zhu","year":"2017","journal-title":"J Med Chem"},{"key":"2020080407010988900_ref24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41571-019-0270-9","article-title":"WEE1 kinase inhibitor shows promise","volume":"16","author":"Sidaway","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"2020080407010988900_ref25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/bioinformatics\/btp036","article-title":"Fragment-based identification of druggable \u2018hot spots\u2019 of proteins using Fourier domain correlation techniques","volume":"25","author":"Brenke","year":"2009","journal-title":"Bioinformatics"},{"key":"2020080407010988900_ref26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1021\/ci800324m","article-title":"Identifying and characterizing binding sites and assessing druggability","volume":"49","author":"Halgren","year":"2009","journal-title":"J Chem Inf Model"},{"key":"2020080407010988900_ref27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nprot.2015.043","article-title":"The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins","volume":"10","author":"Kozakov","year":"2015","journal-title":"Nat Protoc"},{"key":"2020080407010988900_ref28","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btr651","article-title":"FTSite: high accuracy detection of ligand binding sites on unbound protein structures","volume":"28","author":"Ngan","year":"2012","journal-title":"Bioinformatics"},{"key":"2020080407010988900_ref29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jmb.2011.09.011","article-title":"Analysis of binding site hot spots on the surface of Ras GTPase","volume":"413","author":"Buhrman","year":"2011","journal-title":"J Mol Biol"},{"key":"2020080407010988900_ref30","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.1038\/s41598-019-42618-8","article-title":"Analysis of tractable allosteric sites in G protein-coupled receptors","volume":"9","author":"Wakefield","year":"2019","journal-title":"Sci Rep"},{"key":"2020080407010988900_ref31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nprot.2015.053","article-title":"The Phyre2 web portal for protein modeling, prediction and analysis","volume":"10","author":"Kelley","year":"2015","journal-title":"Nat Protoc"},{"key":"2020080407010988900_ref32","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jmb.2010.01.074","article-title":"Protein folding requires crowd control in a simulated cell","volume":"397","author":"Jefferys","year":"2010","journal-title":"J Mol Biol"},{"key":"2020080407010988900_ref33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/adt.2009.0222","article-title":"ADP-Glo: a bioluminescent and homogeneous ADP monitoring assay for kinases","volume":"7","author":"Zegzouti","year":"2009","journal-title":"Assay Drug Dev Technol"},{"key":"2020080407010988900_ref34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/adt.2008.151","article-title":"Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agents","volume":"6","author":"Johnston","year":"2008","journal-title":"Assay Drug Dev Technol"},{"key":"2020080407010988900_ref35","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ptr.5065","article-title":"High throughput screening of natural products for anti-mitotic effects in MDA-MB-231 human breast carcinoma cells","volume":"28","author":"Mazzio","year":"2014","journal-title":"Phytother Res"},{"key":"2020080407010988900_ref36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tcb.2013.03.002","article-title":"Cell cycle control across the eukaryotic kingdom","volume":"23","author":"Harashima","year":"2013","journal-title":"Trends Cell Biol"},{"key":"2020080407010988900_ref37","first-page":"44","article-title":"The ovarian follicle of cows as a model for human","volume":"127","author":"Sirard","year":"2017","journal-title":"Anim Models Hum Reprod"},{"key":"2020080407010988900_ref38","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/cyto.a.23105","article-title":"Quantitative analysis of cell proliferation by a dye dilution assay: application to cell lines and cocultures","volume":"91","author":"Chung","year":"2017","journal-title":"Cytometry A"},{"key":"2020080407010988900_ref39","doi-asserted-by":"crossref","first-page":"e12913","DOI":"10.1371\/journal.pone.0012913","article-title":"Crystal structure of human AKT1 with an allosteric inhibitor reveals a new mode of kinase inhibition","volume":"5","author":"Wu","year":"2010","journal-title":"PLoS One"},{"key":"2020080407010988900_ref40","doi-asserted-by":"crossref","first-page":"e15929","DOI":"10.1371\/journal.pone.0015929","article-title":"Allosteric interactions between the myristate- and ATP-site of the Abl kinase","volume":"6","author":"Iacob","year":"2011","journal-title":"PLoS One"},{"key":"2020080407010988900_ref41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nchembio760","article-title":"Allosteric inhibitors of Bcr-abl-dependent cell proliferation","volume":"2","author":"Adrian","year":"2006","journal-title":"Nat Chem Biol"},{"key":"2020080407010988900_ref42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature08675","article-title":"Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors","volume":"463","author":"Zhang","year":"2010","journal-title":"Nature"},{"key":"2020080407010988900_ref43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1021\/ml100044h","article-title":"Allosteric IGF-1R inhibitors","volume":"1","author":"Heinrich","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"2020080407010988900_ref44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bmcl.2008.12.076","article-title":"Development of thioquinazolinones, allosteric Chk1 kinase inhibitors","volume":"19","author":"Converso","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"2020080407010988900_ref45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1021\/cb1002619","article-title":"Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases","volume":"6","author":"Comess","year":"2011","journal-title":"ACS Chem Biol"},{"key":"2020080407010988900_ref46","doi-asserted-by":"crossref","first-page":"104609","DOI":"10.1016\/j.phrs.2019.104609","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update","volume":"152","author":"Roskoski","year":"2020","journal-title":"Pharmacol Res"},{"key":"2020080407010988900_ref47","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1021\/acs.jmedchem.8b01040","article-title":"Discovery of Asciminib (ABL001), an allosteric inhibitor of the tyrosine kinase activity of BCR-ABL1","volume":"61","author":"Schoepfer","year":"2018","journal-title":"J Med Chem"},{"key":"2020080407010988900_ref48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ajhg.2017.08.018","article-title":"Biallelic mutations in PATL2 cause female infertility characterized by oocyte maturation arrest","volume":"101","author":"Chen","year":"2017","journal-title":"Am J Hum Genet"},{"key":"2020080407010988900_ref49","doi-asserted-by":"crossref","first-page":"e8515","DOI":"10.15252\/emmm.201708515","article-title":"PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice","volume":"10","author":"Christou-Kent","year":"2018","journal-title":"EMBO Mol Med"},{"key":"2020080407010988900_ref50","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41431-018-0283-3","article-title":"The comprehensive mutational and phenotypic spectrum of TUBB8 in female infertility","volume":"27","author":"Chen","year":"2019","journal-title":"Eur J Hum Genet"},{"key":"2020080407010988900_ref51","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708515","article-title":"PATL2 is a key actor of oocyte maturation whose invalidation causes infertility in women and mice","volume":"10","author":"Christou-Kent","year":"2018","journal-title":"EMBO Mol Med"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioaa097\/33498047\/ioaa097.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/103\/2\/368\/33563266\/ioaa097.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/103\/2\/368\/33563266\/ioaa097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T11:05:13Z","timestamp":1596539113000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/103\/2\/368\/5856457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6,12]]},"published-print":{"date-parts":[[2020,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioaa097","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,6,12]]}}}